• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

呼吸道合胞病毒(RSV)在西班牙成年人中的负担与流感相比如何?

How Does the Burden of Respiratory Syncytial Virus Compare to Influenza in Spanish Adults?

机构信息

Translational Pediatrics and Infectious Diseases, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.

Genetics, Vaccines and Pediatric Infectious Diseases Research Group, Instituto de Investigación Sanitaria de Santiago, Universidad de Santiago, Santiago de Compostela, Spain.

出版信息

Influenza Other Respir Viruses. 2024 Jun;18(6):e13341. doi: 10.1111/irv.13341.

DOI:10.1111/irv.13341
PMID:38923767
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11194680/
Abstract

BACKGROUND

Respiratory syncytial virus (RSV) and influenza infections cause significant annual morbidity and mortality worldwide in at-risk populations. This study is aimed at assessing hospital burden and healthcare resource utilization (HRU) of RSV and influenza in adults in Spain.

METHODS

Data were obtained from the Projected Hospitalisation Database of inpatient episodes (ages: younger adults 18-50 and 51-64 years; older adults 65-74, 75-84, and ≥ 85 years) during 2015, 2017, and 2018 in Spanish public hospitals. Incidence, mean hospitalization, and HRU assessments, including length of stay (LOS), intensive care unit (ICU) usage, and age-standardized mortality rates, were collected and stratified by age group, with analyses focusing on the adult population (≥ 18 years old).

RESULTS

Mean hospitalization rate in the population across all years was lower in individuals with RSV versus influenza (7.2/100,000 vs. 49.7/100,000 individuals). ICU admissions and median LOS were similar by age group for both viruses. Age-standardized mortality was 6.3/100,000 individuals and 6.1/100,000 individuals in patients with RSV and influenza, respectively, and mortality rates were similar in older adults (≥ 65 years) for both viruses.

CONCLUSIONS

RSV and influenza infection were associated with considerable HRU. There is a substantial disease burden for RSV infection in older adults ≥ 65 years. While RSV hospitalization rates in adults reported here appeared lower than influenza, RSV is still underdiagnosed in the hospital setting and its incidence might be similar to, or higher than, influenza.

摘要

背景

呼吸道合胞病毒(RSV)和流感感染在全球高危人群中造成了显著的年发病率和死亡率。本研究旨在评估西班牙成人中 RSV 和流感的医院负担和医疗资源利用(HRU)。

方法

数据来自 2015 年、2017 年和 2018 年西班牙公立医院住院患者项目住院病例数据库(年龄:年轻成年人 18-50 岁和 51-64 岁;老年人 65-74 岁、75-84 岁和≥85 岁)。收集发病率、平均住院时间和 HRU 评估数据,包括住院时间(LOS)、重症监护病房(ICU)使用率和年龄标准化死亡率,并按年龄组分层,分析重点为成年人群(≥18 岁)。

结果

所有年份人群中 RSV 的平均住院率低于流感(7.2/10 万与 49.7/10 万)。两种病毒的 ICU 入院率和中位 LOS 在各年龄段相似。RSV 和流感患者的年龄标准化死亡率分别为 6.3/10 万和 6.1/10 万,两种病毒在≥65 岁的老年人中的死亡率相似。

结论

RSV 和流感感染与大量 HRU 相关。≥65 岁的老年人 RSV 感染负担很大。虽然这里报告的成人 RSV 住院率似乎低于流感,但 RSV 在医院环境中仍被漏诊,其发病率可能与流感相似,甚至高于流感。

相似文献

1
How Does the Burden of Respiratory Syncytial Virus Compare to Influenza in Spanish Adults?呼吸道合胞病毒(RSV)在西班牙成年人中的负担与流感相比如何?
Influenza Other Respir Viruses. 2024 Jun;18(6):e13341. doi: 10.1111/irv.13341.
2
Hospitalization cost estimates of respiratory syncytial virus and influenza infections in adults in Spain, 2016-2019.2016 - 2019年西班牙成人呼吸道合胞病毒和流感感染的住院费用估计
Vaccine. 2025 Feb 6;46:126683. doi: 10.1016/j.vaccine.2024.126683. Epub 2024 Dec 27.
3
Burden of Respiratory Syncytial Virus-Associated Hospitalizations in US Adults, October 2016 to September 2023.美国成年人呼吸道合胞病毒相关住院负担,2016 年 10 月至 2023 年 9 月。
JAMA Netw Open. 2024 Nov 4;7(11):e2444756. doi: 10.1001/jamanetworkopen.2024.44756.
4
Severity of respiratory syncytial virus compared with SARS-CoV-2 and influenza among hospitalised adults ≥65 years.65 岁及以上住院成年人中呼吸道合胞病毒与 SARS-CoV-2 和流感的严重程度比较。
J Infect. 2024 Nov;89(5):106292. doi: 10.1016/j.jinf.2024.106292. Epub 2024 Sep 26.
5
Economic burden of children hospitalized with respiratory syncytial virus infection in Spain, 2016-2019.2016 - 2019年西班牙呼吸道合胞病毒感染住院儿童的经济负担
Vaccine. 2025 Jan 1;43(Pt 2):126512. doi: 10.1016/j.vaccine.2024.126512. Epub 2024 Nov 7.
6
Respiratory Syncytial Virus vs Influenza Virus Infection: Mortality and Morbidity Comparison Over 7 Epidemic Seasons in an Elderly Population.呼吸道合胞病毒与流感病毒感染:老年人群中 7 个流行季节的死亡率和发病率比较。
J Infect Dis. 2024 Nov 15;230(5):1130-1138. doi: 10.1093/infdis/jiae171.
7
Adult Respiratory Syncytial Virus Infection: Defining Incidence, Risk Factors for Hospitalization, and Poor Outcomes, a Regional Cohort Study, 2016-2022.成人呼吸道合胞病毒感染:确定发病率、住院风险因素及不良结局,一项2016 - 2022年的区域队列研究
Pathogens. 2024 Aug 31;13(9):750. doi: 10.3390/pathogens13090750.
8
Severity and outcomes of adult respiratory syncytial virus inpatient compared with influenza: observational study from Japan.成人呼吸道合胞病毒住院患者与流感患者相比的严重程度及结局:来自日本的观察性研究
Infect Dis (Lond). 2025 Apr;57(4):366-375. doi: 10.1080/23744235.2025.2450590. Epub 2025 Feb 4.
9
Morbidity and mortality of respiratory syncytial virus infection in hospitalized adults: Comparison with seasonal influenza.住院成人呼吸道合胞病毒感染的发病率和死亡率:与季节性流感的比较。
Int J Infect Dis. 2021 Feb;103:489-493. doi: 10.1016/j.ijid.2020.11.185. Epub 2020 Nov 26.
10
Clinical characteristics and outcome of respiratory syncytial virus infection among adults hospitalized with influenza-like illness in France.法国流感样疾病住院成人中呼吸道合胞病毒感染的临床特征与转归
Clin Microbiol Infect. 2017 Apr;23(4):253-259. doi: 10.1016/j.cmi.2016.11.014. Epub 2016 Nov 27.

引用本文的文献

1
Respiratory Syncytial Virus and Human Metapneumovirus Respiratory Hospitalizations and Outcomes in Colorado Adults ≥50 Years of Age: 2016-2023.呼吸道合胞病毒和人偏肺病毒导致科罗拉多州50岁及以上成年人的呼吸道住院情况及转归:2016 - 2023年
J Infect Dis. 2025 Jul 16;232(Supplement_1):S19-S28. doi: 10.1093/infdis/jiaf266.
2
Severity of Respiratory Viral Diseases and the Impacts of Underlying Medical Conditions During the Omicron Subvariant Dominant Epidemics-A Comparative Study of SARS-CoV-2, Influenza Virus and Respiratory Syncytial Virus.奥密克戎变异株主导流行期间呼吸道病毒疾病的严重程度及基础疾病的影响——严重急性呼吸综合征冠状病毒2、流感病毒和呼吸道合胞病毒的比较研究
Pathogens. 2025 May 29;14(6):543. doi: 10.3390/pathogens14060543.
3
[Validity of case definitions for Severe Acute Respiratory Infection based on ICD-10 codes in four autonomous communities (Spain, 2021-2023)].[基于国际疾病分类第十版(ICD - 10)编码的四个自治区严重急性呼吸道感染病例定义的有效性(西班牙,2021 - 2023年)]
Rev Esp Salud Publica. 2025 May 21;99:e202505025.
4
Addressing the Underestimated Burden of RSV in Older Adults in Europe: Epidemiology, Surveillance Gaps, and Public Health Implications.应对欧洲老年人中被低估的呼吸道合胞病毒负担:流行病学、监测差距及对公共卫生的影响
Vaccines (Basel). 2025 May 12;13(5):510. doi: 10.3390/vaccines13050510.
5
Unveiling the Spectrum of Respiratory Syncytial Virus Disease in Adults: From Community to Hospital.揭示成人呼吸道合胞病毒疾病的全貌:从社区到医院
Influenza Other Respir Viruses. 2025 May;19(5):e70107. doi: 10.1111/irv.70107.
6
Hospitalisation due to respiratory syncytial virus in a population-based cohort of older adults in Spain, 2016/17 to 2019/20.2016/17至2019/20年西班牙以人群为基础的老年人群队列中因呼吸道合胞病毒导致的住院情况。
Euro Surveill. 2025 Mar;30(10). doi: 10.2807/1560-7917.ES.2025.30.10.2400364.

本文引用的文献

1
Estimated Respiratory Syncytial Virus-Related Hospitalizations and Deaths Among Children and Adults in Spain, 2016-2019.2016 - 2019年西班牙儿童和成人中估计与呼吸道合胞病毒相关的住院和死亡情况
Infect Dis Ther. 2024 Mar;13(3):463-480. doi: 10.1007/s40121-024-00920-7. Epub 2024 Feb 6.
2
The Path Towards Effective Respiratory Syncytial Virus Immunization Policies: Recommended Actions.迈向有效呼吸道合胞病毒免疫接种政策之路:建议采取的行动。
Arch Bronconeumol. 2023 Sep;59(9):581-588. doi: 10.1016/j.arbres.2023.06.006. Epub 2023 Jun 20.
3
Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants.孕期接种二价融合前F疫苗预防婴儿呼吸道合胞病毒疾病
N Engl J Med. 2023 Apr 20;388(16):1451-1464. doi: 10.1056/NEJMoa2216480. Epub 2023 Apr 5.
4
Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults.一种二价呼吸道合胞病毒预融合F疫苗在老年人中的疗效和安全性
N Engl J Med. 2023 Apr 20;388(16):1465-1477. doi: 10.1056/NEJMoa2213836. Epub 2023 Apr 5.
5
Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults.老年人呼吸道合胞病毒预融合F蛋白疫苗
N Engl J Med. 2023 Feb 16;388(7):595-608. doi: 10.1056/NEJMoa2209604.
6
Global burden of lower respiratory infections during the last three decades.过去三十年下呼吸道感染的全球负担。
Front Public Health. 2023 Jan 9;10:1028525. doi: 10.3389/fpubh.2022.1028525. eCollection 2022.
7
Impact of Respiratory Syncytial Virus and Influenza Virus Infection in the Adult Population in Spain between 2012 and 2020.2012 年至 2020 年期间西班牙成人人群中呼吸道合胞病毒和流感病毒感染的影响。
Int J Environ Res Public Health. 2022 Nov 9;19(22):14680. doi: 10.3390/ijerph192214680.
8
Burden of respiratory syncytial virus infection in older and high-risk adults: a systematic review and meta-analysis of the evidence from developed countries.发达国家中老年人和高危成年人呼吸道合胞病毒感染负担:系统评价和荟萃分析。
Eur Respir Rev. 2022 Nov 15;31(166). doi: 10.1183/16000617.0105-2022. Print 2022 Dec 31.
9
The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study.在欧洲,健康足月出生婴儿中的呼吸道合胞病毒负担:一项前瞻性出生队列研究。
Lancet Respir Med. 2023 Apr;11(4):341-353. doi: 10.1016/S2213-2600(22)00414-3. Epub 2022 Nov 10.
10
Clinical and economic burden of respiratory syncytial virus in Spanish children: the BARI study.西班牙儿童呼吸道合胞病毒的临床和经济负担:BARI 研究。
BMC Infect Dis. 2022 Sep 29;22(1):759. doi: 10.1186/s12879-022-07745-0.